New diagnostic tools for delineating iron status

Area of Science:

• Hematology
• Iron Metabolism
• Erythropoiesis

Background:

• Hepcidin regulates iron by binding ferroportin, controlling cellular iron levels.
• Erythroferrone, a hormone from bone marrow, influences hepcidin levels during erythropoiesis.
• Dysregulation of hepcidin is implicated in various anemias and iron overload disorders.

Observation:

• Increased hepcidin causes iron sequestration, leading to iron-restricted erythropoiesis.
• Decreased hepcidin, influenced by erythroferrone, can result in iron overload.
• Iron deficiency anemia involves impaired hemoglobin synthesis and reduced erythropoietin response.

Findings:

• Current tools for identifying iron deficiency in anemic patients are being reviewed.
• Novel markers including hepcidin, erythroferrone, and iron restriction response markers are being evaluated.
• The clinical utility of these markers for understanding health outcomes in challenging cases is assessed.

Implications:

• Translating recent advances in iron metabolism and erythropoiesis understanding to clinical practice is crucial.
• Evaluating new biomarkers may enhance diagnostic accuracy and therapeutic strategies for anemia.
• This review aims to bridge the gap between research findings and clinical application in iron-related anemias.